Annual EBITDA:
$316.89M+$770.58M(+169.85%)Summary
- As of today, SRPT annual EBITDA is $316.89 million, with the most recent change of +$770.58 million (+169.85%) on December 31, 2024.
- During the last 3 years, SRPT annual EBITDA has risen by +$634.29 million (+199.84%).
- SRPT annual EBITDA is now at all-time high.
Performance
SRPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$41.06M-$171.50M(-131.48%)Summary
- As of today, SRPT quarterly EBITDA is -$41.06 million, with the most recent change of -$171.50 million (-131.48%) on September 30, 2025.
- Over the past year, SRPT quarterly EBITDA has dropped by -$77.39 million (-213.03%).
- SRPT quarterly EBITDA is now -123.33% below its all-time high of $176.01 million, reached on December 31, 2024.
Performance
SRPT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$21.08M-$77.39M(-137.44%)Summary
- As of today, SRPT TTM EBITDA is -$21.08 million, with the most recent change of -$77.39 million (-137.44%) on September 30, 2025.
- Over the past year, SRPT TTM EBITDA has dropped by -$156.89 million (-115.52%).
- SRPT TTM EBITDA is now -107.75% below its all-time high of $271.97 million, reached on December 31, 2024.
Performance
SRPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SRPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +169.8% | -213.0% | -115.5% |
| 3Y3 Years | +199.8% | +64.9% | +95.7% |
| 5Y5 Years | +148.1% | +67.7% | +96.3% |
SRPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +153.3% | -123.3% | +85.7% | -107.8% | +96.0% |
| 5Y | 5-Year | at high | +148.1% | -123.3% | +85.7% | -107.8% | +96.3% |
| All-Time | All-Time | at high | +148.1% | -123.3% | +85.7% | -107.8% | +96.3% |
SRPT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$41.06M(-131.5%) | -$21.08M(-137.4%) |
| Jun 2025 | - | $130.44M(+145.5%) | $56.31M(+190.7%) |
| Mar 2025 | - | -$286.47M(-262.8%) | -$62.10M(-122.8%) |
| Dec 2024 | $316.89M(+169.8%) | $176.01M(+384.5%) | $271.97M(+100.3%) |
| Sep 2024 | - | $36.33M(+202.0%) | $135.81M(+45.4%) |
| Jun 2024 | - | $12.03M(-74.7%) | $93.40M(+347.3%) |
| Mar 2024 | - | $47.60M(+19.4%) | -$37.77M(+81.9%) |
| Dec 2023 | -$453.69M(+23.7%) | $39.86M(+754.6%) | -$208.93M(+38.8%) |
| Sep 2023 | - | -$6.09M(+94.9%) | -$341.51M(+24.5%) |
| Jun 2023 | - | -$119.13M(+3.6%) | -$452.41M(+15.1%) |
| Mar 2023 | - | -$123.56M(-33.3%) | -$532.66M(-10.6%) |
| Dec 2022 | -$594.85M(-87.4%) | -$92.73M(+20.7%) | -$481.60M(+0.6%) |
| Sep 2022 | - | -$116.98M(+41.3%) | -$484.54M(-25.1%) |
| Jun 2022 | - | -$199.38M(-175.0%) | -$387.43M(-12.8%) |
| Mar 2022 | - | -$72.51M(+24.2%) | -$343.37M(+14.5%) |
| Dec 2021 | -$317.41M(+31.9%) | -$95.67M(-381.4%) | -$401.58M(+13.7%) |
| Sep 2021 | - | -$19.87M(+87.2%) | -$465.16M(+18.7%) |
| Jun 2021 | - | -$155.32M(-18.8%) | -$572.38M(-4.9%) |
| Mar 2021 | - | -$130.72M(+17.9%) | -$545.70M(-4.1%) |
| Dec 2020 | -$466.21M(+29.2%) | -$159.25M(-25.3%) | -$524.32M(+9.1%) |
| Sep 2020 | - | -$127.09M(+1.2%) | -$576.89M(-2.1%) |
| Jun 2020 | - | -$128.64M(-17.6%) | -$565.11M(-6.4%) |
| Mar 2020 | - | -$109.34M(+48.4%) | -$530.90M(-8.0%) |
| Dec 2019 | -$658.71M(-108.0%) | -$211.81M(-83.7%) | -$491.58M(-19.4%) |
| Sep 2019 | - | -$115.31M(-22.1%) | -$411.80M(-13.4%) |
| Jun 2019 | - | -$94.43M(-34.9%) | -$362.99M(+2.2%) |
| Mar 2019 | - | -$70.02M(+47.0%) | -$371.33M(-12.6%) |
| Dec 2018 | -$316.66M(-811.6%) | -$132.04M(-98.5%) | -$329.81M(-50.9%) |
| Sep 2018 | - | -$66.51M(+35.3%) | -$218.54M(-28.7%) |
| Jun 2018 | - | -$102.78M(-260.8%) | -$169.79M(-41.6%) |
| Mar 2018 | - | -$28.49M(-37.1%) | -$119.92M(+6.9%) |
| Dec 2017 | -$34.73M(+86.6%) | -$20.78M(-17.1%) | -$128.80M(+33.9%) |
| Sep 2017 | - | -$17.75M(+66.5%) | -$194.76M(+15.8%) |
| Jun 2017 | - | -$52.91M(-41.6%) | -$231.21M(+3.0%) |
| Mar 2017 | - | -$37.37M(+56.9%) | -$238.30M(+7.9%) |
| Dec 2016 | -$259.76M(-21.7%) | -$86.73M(-60.0%) | -$258.70M(-10.1%) |
| Sep 2016 | - | -$54.20M(+9.7%) | -$235.05M(-1.6%) |
| Jun 2016 | - | -$60.00M(-3.9%) | -$231.31M(-9.0%) |
| Mar 2016 | - | -$57.77M(+8.4%) | -$212.13M(-3.1%) |
| Dec 2015 | -$213.42M(-64.0%) | -$63.09M(-25.0%) | -$205.65M(-10.5%) |
| Sep 2015 | - | -$50.45M(-23.6%) | -$186.13M(-10.6%) |
| Jun 2015 | - | -$40.82M(+20.4%) | -$168.30M(-7.3%) |
| Mar 2015 | - | -$51.30M(-17.7%) | -$156.80M(-21.1%) |
| Dec 2014 | -$130.10M(-46.2%) | -$43.56M(-33.5%) | -$129.50M(-9.4%) |
| Sep 2014 | - | -$32.63M(-11.3%) | -$118.41M(-7.3%) |
| Jun 2014 | - | -$29.31M(-22.1%) | -$110.37M(-12.8%) |
| Mar 2014 | - | -$24.00M(+26.1%) | -$97.89M(-10.7%) |
| Dec 2013 | -$89.01M(-215.9%) | -$32.47M(-32.0%) | -$88.39M(-34.2%) |
| Sep 2013 | - | -$24.59M(-46.1%) | -$65.85M(-37.8%) |
| Jun 2013 | - | -$16.83M(-16.0%) | -$47.79M(-32.2%) |
| Mar 2013 | - | -$14.50M(-46.0%) | -$36.16M(-28.3%) |
| Dec 2012 | -$28.18M(+18.6%) | -$9.93M(-52.1%) | -$28.18M(-10.2%) |
| Sep 2012 | - | -$6.53M(-25.7%) | -$25.56M(+14.9%) |
| Jun 2012 | - | -$5.20M(+20.3%) | -$30.03M(+13.5%) |
| Mar 2012 | - | -$6.52M(+10.9%) | -$34.71M(-3.7%) |
| Dec 2011 | -$34.63M | -$7.32M(+33.5%) | -$33.48M(-21.8%) |
| Sep 2011 | - | -$11.00M(-11.4%) | -$27.49M(-40.7%) |
| Jun 2011 | - | -$9.87M(-86.6%) | -$19.53M(-37.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$5.29M(-299.4%) | -$14.18M(+12.9%) |
| Dec 2010 | -$19.47M(-37.8%) | -$1.32M(+56.4%) | -$16.27M(+12.5%) |
| Sep 2010 | - | -$3.04M(+32.6%) | -$18.60M(-2.6%) |
| Jun 2010 | - | -$4.52M(+38.9%) | -$18.13M(+1.1%) |
| Mar 2010 | - | -$7.39M(-102.1%) | -$18.32M(-29.7%) |
| Dec 2009 | -$14.13M(+12.1%) | -$3.65M(-42.4%) | -$14.13M(-9.2%) |
| Sep 2009 | - | -$2.57M(+45.5%) | -$12.94M(+13.2%) |
| Jun 2009 | - | -$4.71M(-47.2%) | -$14.91M(-1.2%) |
| Mar 2009 | - | -$3.20M(-29.6%) | -$14.73M(+1.9%) |
| Dec 2008 | -$16.07M(+48.3%) | -$2.47M(+45.5%) | -$15.01M(+15.2%) |
| Sep 2008 | - | -$4.53M(-0.0%) | -$17.71M(+16.3%) |
| Jun 2008 | - | -$4.53M(-30.1%) | -$21.15M(+15.3%) |
| Mar 2008 | - | -$3.48M(+32.5%) | -$24.97M(+21.1%) |
| Dec 2007 | -$31.09M(-0.7%) | -$5.16M(+35.3%) | -$31.63M(+8.9%) |
| Sep 2007 | - | -$7.97M(+4.5%) | -$34.71M(-3.7%) |
| Jun 2007 | - | -$8.35M(+17.7%) | -$33.49M(-4.5%) |
| Mar 2007 | - | -$10.14M(-23.0%) | -$32.04M(-3.7%) |
| Dec 2006 | -$30.89M(-99.1%) | -$8.24M(-22.1%) | -$30.89M(-14.3%) |
| Sep 2006 | - | -$6.75M(+2.3%) | -$27.03M(-24.5%) |
| Jun 2006 | - | -$6.91M(+23.2%) | -$21.70M(-11.6%) |
| Mar 2006 | - | -$8.99M(-105.6%) | -$19.45M(-25.3%) |
| Dec 2005 | -$15.52M(+33.0%) | -$4.38M(-206.9%) | -$15.52M(+0.3%) |
| Sep 2005 | - | -$1.43M(+69.4%) | -$15.56M(+17.1%) |
| Jun 2005 | - | -$4.66M(+8.0%) | -$18.78M(+10.1%) |
| Mar 2005 | - | -$5.06M(-14.6%) | -$20.89M(+9.8%) |
| Dec 2004 | -$23.16M(-33.2%) | -$4.42M(+4.9%) | -$23.16M(+9.0%) |
| Sep 2004 | - | -$4.65M(+31.3%) | -$25.44M(-1.3%) |
| Jun 2004 | - | -$6.77M(+7.6%) | -$25.12M(-16.5%) |
| Mar 2004 | - | -$7.32M(-9.3%) | -$21.57M(-24.0%) |
| Dec 2003 | -$17.39M(+27.6%) | -$6.70M(-54.8%) | -$17.39M(-20.3%) |
| Sep 2003 | - | -$4.33M(-34.9%) | -$14.46M(+4.6%) |
| Jun 2003 | - | -$3.21M(-1.9%) | -$15.15M(+22.4%) |
| Mar 2003 | - | -$3.15M(+16.6%) | -$19.53M(+18.7%) |
| Dec 2002 | -$24.01M(-61.7%) | -$3.77M(+24.9%) | -$24.01M(+2.4%) |
| Sep 2002 | - | -$5.02M(+33.8%) | -$24.60M(-7.9%) |
| Jun 2002 | - | -$7.58M(+0.6%) | -$22.81M(-20.7%) |
| Mar 2002 | - | -$7.63M(-74.7%) | -$18.90M(-28.4%) |
| Dec 2001 | -$14.85M(-51.1%) | -$4.37M(-35.3%) | -$14.72M(-11.7%) |
| Sep 2001 | - | -$3.23M(+12.2%) | -$13.18M(-5.8%) |
| Jun 2001 | - | -$3.68M(-6.6%) | -$12.45M(-8.2%) |
| Mar 2001 | - | -$3.45M(-22.0%) | -$11.51M(-24.7%) |
| Dec 2000 | -$9.82M(-22.8%) | -$2.83M(-12.8%) | -$9.23M(-46.2%) |
| Sep 2000 | - | -$2.50M(+8.4%) | -$6.32M(-5.7%) |
| Jun 2000 | - | -$2.73M(-134.1%) | -$5.97M(-14.6%) |
| Mar 2000 | - | -$1.17M(-1391.9%) | -$5.21M(+10.0%) |
| Dec 1999 | -$8.00M(-5.3%) | $90.40K(+104.2%) | -$5.79M(+0.4%) |
| Sep 1999 | - | -$2.16M(-9.5%) | -$5.82M(-5.5%) |
| Jun 1999 | - | -$1.97M(-13.0%) | -$5.51M(-4.2%) |
| Mar 1999 | - | -$1.75M(-2745.8%) | -$5.29M(-4.1%) |
| Dec 1998 | -$7.60M(-123.5%) | $66.00K(+103.5%) | -$5.09M(+14.5%) |
| Sep 1998 | - | -$1.86M(-6.2%) | -$5.95M(-19.2%) |
| Jun 1998 | - | -$1.75M(-13.9%) | -$4.99M(-17.8%) |
| Mar 1998 | - | -$1.54M(-92.4%) | -$4.24M(-32.5%) |
| Dec 1997 | -$3.40M(-100.0%) | -$800.00K(+11.1%) | -$3.20M(-33.3%) |
| Sep 1997 | - | -$900.00K(+10.0%) | -$2.40M(-60.0%) |
| Jun 1997 | - | -$1.00M(-100.0%) | -$1.50M(-200.0%) |
| Mar 1997 | - | -$500.00K | -$500.00K |
| Dec 1996 | -$1.70M | - | - |
FAQ
- What is Sarepta Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Sarepta Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Sarepta Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Sarepta Therapeutics, Inc.?
- What is Sarepta Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Sarepta Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of SRPT is $316.89M
What is the all-time high annual EBITDA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high annual EBITDA is $316.89M
What is Sarepta Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, SRPT annual EBITDA has changed by +$770.58M (+169.85%)
What is Sarepta Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of SRPT is -$41.06M
What is the all-time high quarterly EBITDA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high quarterly EBITDA is $176.01M
What is Sarepta Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, SRPT quarterly EBITDA has changed by -$77.39M (-213.03%)
What is Sarepta Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of SRPT is -$21.08M
What is the all-time high TTM EBITDA for Sarepta Therapeutics, Inc.?
Sarepta Therapeutics, Inc. all-time high TTM EBITDA is $271.97M
What is Sarepta Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, SRPT TTM EBITDA has changed by -$156.89M (-115.52%)